(1 - 7 von 8
)
COMMUNIQUÉS West-GlobeNewswire | Page | santé logwww.santelog.com › communiques...
www.santelog.com
... Dr. Ulrich Dauer to team up with Chief Development Officer, Dr. Inge Lues, effective May 1, 2018; Dr. Konrad Glund and Dr. Hendrik Liebers to continue in [...] ...
Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive
www.globenewswire.com
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px;...
Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive Officer -...
www.teletrader.com
.TeletraderNews
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} .TeletraderNews table.hugin { border-color:black;} .TeletraderNews td.hugin {...
Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive Officer |...
www.technologiepark-weinberg-campus.de
· Inge Lues in advancing Probiodrug's unique drug candidate PQ912, towards Phase 2b, i.e. clinical proof of concept. For this, a clinical trial ...
sortiert nach Relevanz / Datum